ArticleBMC pediatrics2025
Prognostic value of cardiac biomarkers and Phoenix criteria in pediatric sepsis: a retrospective cohort study.
Article in BMC pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The role of N-terminal probrain natriuretic peptide in predicting Kawasaki disease shock syndrome: a prospective cohort study.European journal of pediatrics · 2026Article
- Septic Cardiomyopathy: Age-Dependent Physiology and Hemodynamic Aspects-A Narrative Review.Children (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study investigated the effects of cardiac biomarkers at admission on the prognosis and timing of vasoactive drug administration in children with sepsis according to the 2005 SIRS criteria. Additionally, the Phoenix sepsis criteria have been applied to patients and examined in detail.
methodsThe study was conducted as a single-center retrospective study between March 2019 and 2022. Laboratory parameters and echocardiographic measurements at admission were evaluated. The primary outcomes are mortality and vasoactive drug use. Receiver operating characteristic (ROC) analysis was used to determine the time to initiate vasoactive drugs.
resultsIn this study 162 (45.1% females) children with sepsis were included. The total mortality was 26.4%. Among the 162 patients, 28.6% were not classified as having sepsis according to the Phoenix 4 criteria and 24.2% according to the Phoenix 8 criteria. Among the non-surviving patients, 9.3% were not classified as sepsis according to the Phoenix 4 criteria (p = 0.001) and 7% according to the Phoenix 8 criteria (p = 0.002). ROC analysis revealed that a pro-BNP value of ≥ 1835 ng/L predicted the initiation of vasoactive therapy with 73.1% sensitivity and 90.9% specificity (p = 0.002).
conclusionsLaboratory parameters such as pro-BNP obtained in the early stages of the disease could serve as good guides for in determining the timing of initiation of vasoactive drug therapy. Furthermore, the fact that children who died did not meet the Phoenix sepsis criteria raises concerns about the ability of these criteria to detect sepsis at an early stage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.